|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2404614 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11184308.2 |
| Date of filing the European patent application | 2007-12-20 | |
| (97) | Date of publication of the European application | 2012-01-11 |
| (45) | Date of publication and mention of the grant of the patent | 2015-06-17 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 876222 P | 2006-12-20 | US |
| (72) |
Fakhrai, Habib, US
Shawler, Daniel L., US
|
| (73) |
Novarx,
6828 Nancy Ridge Drive, Suite 100, San Diego CA 92121-2635,
US
|
| (54) | Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization |
| Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization |